Milk Concentrations (milk + concentration)

Distribution by Scientific Domains


Selected Abstracts


Effect of protein : energy ratio in milk replacers on growth performance of goat kids

JOURNAL OF ANIMAL PHYSIOLOGY AND NUTRITION, Issue 5-6 2002
K-H. YEOM
Two separate experiments were carried out to establish the effects of the protein : energy ratio in milk replacers on growth performance, plasma lipid concentrations and fatty acid composition in adipose tissue of male goat kids. In the first experiment there were 211 3-day- old goat kids and in the second experiment there were 121 kids aged 3,7 days. The animals were fed ad libitum for a period of 4 weeks on milk replacers containing either 11.5 or 9.5 g crude protein/MJ metabolizable energy. In essence, protein was exchanged with fat on a weight basis. Milk concentrations were increased from 160 to 190 g/l in experiment 1, from 150 to 180 g/l in experiment 2. There were significant increases in body weight and feed intake when the milk replacer with high protein : energy ratio was fed. Group mean average daily weight gain was 168 and 203 g for the groups with low and high dietary protein : energy ratio in experiment 1; for experiment 2 the values were 139 and 160 g. Average dry matter intake was 18 and 14% higher for the diet with high protein : energy ratio in experiments 1 and 2, respectively. There was no change in either feed conversion (feed : gain ratio) or energy conversion (weight gain : energy intake ratio). There were no consistent diet effects on plasma lipid concentrations. Dietary fatty acid composition was reflected by that of adipose tissue. The milk replacer with high protein : energy ratio produced a small increase in the contents of myristic and palmitic acid in adipose tissue. [source]


The concordance test emerges as a powerful tool for identifying quantitative trait nucleotides: lessons from BTA6 milk yield QTL

ANIMAL GENETICS, Issue 2 2009
E. Seroussi
Summary The lack of conventions for confirming the discovery of quantitative trait nucleotides in livestock was evidenced by the proposals of mutations in two different genes (SPP1 and ABCG2) as the underlying functional mutation for a major quantitative trait locus (QTL) for milk concentration on bovine chromosome 6 (BTA6). Of these conflicting candidates, SPP1 was excluded by follow-up studies and by the data described here. A simple test for concordance of the zygosity state between QTL segregation status and the candidate polymorphism was shown, in this case, to be a critical step towards establishing the proof. If a given sample effectively represents the genetic variation across the QTL region, haplotype-based concordance may further enhance the functionality and resolution power of this test, allowing identification of the causative gene. [source]


Pharmacokinetics of ketamine in plasma and milk of mature Holstein cows

JOURNAL OF VETERINARY PHARMACOLOGY & THERAPEUTICS, Issue 5 2010
G. SELLERS
Sellers, G., Lin, H. C., G. Riddell, M. G., Ravis, W. R., Lin, Y. J., Duran, S. H., Givens, M.D. Pharmacokinetics of ketamine in plasma and milk of mature Holstein cows. J. vet. Pharmacol. Therap. 33, 480,484. The purpose of this study was to evaluate the pharmacokinetics of ketamine in mature Holstein cows following administration of a single intravenous (i.v.) dose. Plasma and milk concentrations were determined using a high-performance liquid chromatography assay. Pharmacokinetic parameters were estimated using a noncompartmental method. Following i.v. administration, plasma Tmax was 0.083 h and plasma Cmax was 18 135 ± 22 720 ng/mL. Plasma AUC was 4484 ± 1,398 ng·h/mL. Plasma t½, was 1.80 ± 0.50 h and mean residence time was 0.794 ± 0.318 h with total body clearance of 1.29 ± 0.70 L/h/kg. The mean plasma steady-state volume of distribution was calculated as 0.990 ± 0.530 L/kg and volume of distribution based on area was calculated as 3.23 ± 1.51 L/kg. The last measurable time for ketamine detection in plasma was 8.0 h with a mean concentration of 24.9 ± 11.8 ng/mL. Milk Tmax was detected at 0.67 ± 0.26 h with Cmax of 2495 ± 904 ng/mL. Milk AUC till the last time was 6593 ± 2617 ng·h/mL with mean AUC milk to AUC plasma ratio of 1.99 ± 2.15. The last measurable time that ketamine was detected in milk was 44 ± 10.0 h with a mean concentration of 16.0 ± 9.0 ng/mL. [source]


Licking induced changes to the pattern of moxidectin milk elimination after topical treatment in dairy cows

JOURNAL OF VETERINARY PHARMACOLOGY & THERAPEUTICS, Issue 6 2009
F. IMPERIALE
Pour-on administration of the macrocyclic lactones anti-parasitic compounds in beef and dairy cattle is now worldwide accepted. However, the information available on their milk excretion pattern, after topical administration is rather limited. Additionally, the cattle licking behaviour has been proven to affect the kinetics of these anti-parasitic compounds. The purpose of this study was to investigate the influence of the natural licking behaviour on the plasma and milk disposition of moxidectin (MXD), topically administered (500 ,g/kg) in lactating dairy cows. Ten lactating Holstein dairy cows (705 kg body weight) were allocated into two experimental groups (n = 5). The licking was prevented during 5 days postadministration in animals in group I, and the remaining cows (group II) were allowed to lick freely. MXD concentrations profiles were measured in plasma and milk over 15 days posttreatment. The licking restriction period caused marked changes in MXD disposition kinetics both in plasma and milk. Both plasma and milk MXD concentrations (partial AUC 0,5 days) were significantly lower (P < 0.05) in licking-restricted cows. After the 5-day of restriction period, the animals were allowed to lick freely, which permitted the oral ingestion of MXD, situation clearly reflected both in plasma profile and milk excretion pattern. Despite the enhanced MXD milk concentrations measured in free-licking cows, drug concentrations did not reach the maximum MXD residues limit. [source]